Jeremy Grushcow - Y Combinator Founder of Sequence Bio
Home›Founders›Jeremy Grushcow
Jeremy Grushcow, Founder of Sequence Bio

Jeremy Grushcow

Founder

Ph.D. in Molecular Genetics and Cell Biology (University of Chicago, 2000); J.D. with Honors (University of Chicago Law School, 2003). Previously: CBO, Sequence Bio S19 (Raised >$10m; LOIs signed with Sema4, Helix and Biogen); EVP, Strategic Development, Antibe Therapeutics (International partnerships, public company financings and disclosures; preclinical through Phase 1 for a novel pain therapeutic) Best dog dad ever; 7 out of 10 human dad.

Previously at

Norton Rose Canada
Norton Rose Canada
Norton Rose Fulbright
Norton Rose Fulbright
Ogilvy Renault
Ogilvy Renault
Shearman and Sterling
Shearman and Sterling
Shearman & Sterling LLP
Shearman & Sterling LLP
Kirkland & Ellis LLP
Kirkland & Ellis LLP
Kirkland & Ellis
Kirkland & Ellis
Alumnus of
University of Chicago
University of Chicago
University of Toronto
University of Toronto